North America radiofrequency-based devices market is projected to grow by 11.0% annually in the forecast period and reach $4,328.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain.
Highlighted with 22 tables and 42 figures, this 101-page report North America Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America radiofrequency-based devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America radiofrequency-based devices market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Generators
Electrodes
Applicators
Probes
Cannulas
Needles
Other Products

Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Pain Management
Aesthetics
Oncology
Cardiology
Gynecology
Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Other End Users

Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ALMA Lasers (Sisram Medical Ltd.)
AngioDynamics, Inc.
AtriCure, Inc.
Avanos Medical, Inc.
Becton Dickinson and Company
Boston Scientific Corporation
Bramsys Industria e Comercio Ltda
BVM Medical Limited
Conmed Corporation
Cutera, Inc.
Cynosure
Diros Technology Inc.
Johnson & Johnson
Medtronic Plc
Merit Medical Systems, Inc.
Smith & Nephew plc
Stryker Corporation
Venus Concept, Inc.
YA-MAN Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)